Company Overview of Aspreva International Ltd.
Aspreva International Ltd. identifies, develops, and commercializes approved drugs and drug candidates for new indications. It evaluates and develops CellCept, an orally delivered immunosuppressant agent, in the treatment of the autoimmune diseases such as lupus nephritis and pemphigus vulgaris. The company operates in the United States, Canada, Switzerland, and the United Kingdom. The company was formerly known as Galenica Canada Ltd. The company was founded in 2001 and is based in Victoria, Canada. Aspreva International Ltd. operates as a subsidiary of Vifor Pharma Ltd.
1203–4464 Markham Street
Victoria, BC V8Z 7X8
Founded in 2001
Key Executives for Aspreva International Ltd.
Similar Private Companies By Industry
|Immune Biotech, Inc.||Americas|
|Swiss Medica Inc.||Americas|
|Aventix Animal Health Corporation||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Aspreva International Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.